These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16186409)

  • 21. The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes.
    Santos IC; Frigeri HR; Réa RR; Almeida AC; Souza EM; Pedrosa FO; Fadel-Picheth CM; Picheth G
    Clin Chim Acta; 2010 Jun; 411(11-12):892-3. PubMed ID: 20227404
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.
    Stone LM; Kahn SE; Deeb SS; Fujimoto WY; Porte D
    Diabetes Care; 1994 Dec; 17(12):1480-3. PubMed ID: 7882822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.
    Vaxillaire M; Veslot J; Dina C; Proença C; Cauchi S; Charpentier G; Tichet J; Fumeron F; Marre M; Meyre D; Balkau B; Froguel P;
    Diabetes; 2008 Jan; 57(1):244-54. PubMed ID: 17977958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men.
    McCarthy MI; Hitman GA; Hitchins M; Riikonen A; Stengård J; Nissinen A; Tuomilehto-Wolf E; Tuomilehto J
    Diabet Med; 1994 Mar; 11(2):198-204. PubMed ID: 8200207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucokinase gene mutations (MODY 2) in Asian Indians.
    Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
    Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses.
    Weedon MN; Clark VJ; Qian Y; Ben-Shlomo Y; Timpson N; Ebrahim S; Lawlor DA; Pembrey ME; Ring S; Wilkin TJ; Voss LD; Jeffery AN; Metcalf B; Ferrucci L; Corsi AM; Murray A; Melzer D; Knight B; Shields B; Smith GD; Hattersley AT; Di Rienzo A; Frayling TM
    Am J Hum Genet; 2006 Dec; 79(6):991-1001. PubMed ID: 17186458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects.
    Grarup N; Urhammer SA; Ek J; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabetologia; 2006 Sep; 49(9):2097-104. PubMed ID: 16865358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians.
    Urhammer SA; Hansen T; Clausen JO; Eiberg H; Pedersen O
    Diabetes; 1998 Aug; 47(8):1359-61. PubMed ID: 9703341
    [No Abstract]   [Full Text] [Related]  

  • 29. The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.
    Lindner I; Rubin D; Helwig U; Nitz I; Hampe J; Schreiber S; Schrezenmeir J; Döring F
    Mol Nutr Food Res; 2006 Mar; 50(3):270-4. PubMed ID: 16521160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women.
    Zaidi FK; Wareham NJ; McCarthy MI; Holdstock J; Kalloo-Hosein H; Krook A; Swinn RA; O'Rahilly S
    Diabet Med; 1997 Mar; 14(3):228-34. PubMed ID: 9088772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion.
    Rose CS; Andersen G; Hamid YH; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabet Med; 2005 Jul; 22(7):946-9. PubMed ID: 15975113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the rs10830963 polymorphism in MTNR1B with fasting glucose, serum adipokine levels and components of metabolic syndrome in adult obese subjects.
    de Luis Román DA; Primo D; Aller R; Izaola O
    Nutr Hosp; 2019 Mar; 36(1):60-65. PubMed ID: 30834760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
    Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
    Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups.
    Freathy RM; Hayes MG; Urbanek M; Lowe LP; Lee H; Ackerman C; Frayling TM; Cox NJ; Dunger DB; Dyer AR; Hattersley AT; Metzger BE; Lowe WL;
    Diabetes; 2010 Oct; 59(10):2682-9. PubMed ID: 20682688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
    Byrne MM; Sturis J; Clément K; Vionnet N; Pueyo ME; Stoffel M; Takeda J; Passa P; Cohen D; Bell GI
    J Clin Invest; 1994 Mar; 93(3):1120-30. PubMed ID: 8132752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up].
    Li X; Liu L; Liang C; Sheng H; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
    Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
    Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.